Polyhydroxybutyrate (PHB) is a polyhydroxyalkanoate (PHA), a polymer belonging to the polyesters class that are of interest as bio-derived and biodegradable plastics.[1] The poly-3-hydroxybutyrate (P3HB) form of PHB is probably the most common type of polyhydroxyalkanoate, but other polymers of this class are produced by a variety of organisms: these include poly-4-hydroxybutyrate (P4HB), polyhydroxyvalerate (PHV), polyhydroxyhexanoate (PHH), polyhydroxyoctanoate (PHO) and their copolymers.

Fermentation can also be used to produce the alcohol needed to produce plastic, although this renewable source of energy is expensive and is not used commercially.[2]


PHB is produced by microorganisms (such as Ralstonia eutrophus or Bacillus megaterium) apparently in response to conditions of physiological stress; mainly conditions in which nutrients are limited. The polymer is primarily a product of carbon assimilation (from glucose or starch) and is employed by microorganisms as a form of energy storage molecule to be metabolized when other common energy sources are not available.

Microbial biosynthesis of PHB starts with the condensation of two molecules of acetyl-CoA to give acetoacetyl-CoA which is subsequently reduced to hydroxybutyryl-CoA. This latter compound is then used as a monomer to polymerize PHB.[3] PHAs granules are then recovered by disrupting the cells.[4]

Thermoplastic polymer

Most commercial plastics are synthetic polymers derived from petrochemicals. They tend to resist biodegradation. PHB-derived plastics are attractive because they are compostable and derived from renewables.

ICI had developed the material to pilot plant stage in the 1980s, but interest faded when it became clear that the cost of material was too high, and its properties could not match those of polypropylene.

In 1996 Monsanto (who sold PHB as a copolymer with PHV under the trade name Biopol) bought all patents for making the polymer from ICI/Zeneca. However, Monsanto's rights to Biopol were sold to the American company Metabolix in 2001[5] and Monsanto's fermenters producing PHB from bacteria were closed down at the start of 2004. Monsanto began to focus on producing PHB from plants instead of bacteria.[6] But now with so much media attention on GM crops, there has been little news of Monsanto's plans for PHB.[7]

In June 2005, a US company, Metabolix, received the Presidential Green Chemistry Challenge Award (small business category) for their development and commercialisation of a cost-effective method for manufacturing PHAs in general, including PHB.

Biopol is currently used in the medical industry for internal suture. It is nontoxic and biodegradable, so it does not have to be removed after recovery.

Properties of PHB

  • Water insoluble and relatively resistant to hydrolytic degradation. This differentiates PHB from most other currently available biodegradable plastics, which are either water soluble or moisture sensitive.
  • Good oxygen permeability.
  • Good ultra-violet resistance but poor resistance to acids and bases.
  • Soluble in chloroform and other chlorinated hydrocarbons.[8]
  • Biocompatible and hence is suitable for medical applications.
  • Melting point 175°C., and glass transition temperature 2°C.
  • Tensile strength 40 MPa, close to that of polypropylene.
  • Sinks in water (while polypropylene floats), facilitating its anaerobic biodegradation in sediments.
  • Nontoxic.
  • Less 'sticky' when melted, making it a potentially good material for clothing in the future


Polyhydroxybutyrate was first isolated and characterized in 1925 by French microbiologist Maurice Lemoigne.[9]


External links

  • Abstract of award for PHAs
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.